Evidence map›Paper›PMID 39959169›Full record

ArticleMolecular vision2024

Global mapping of BMAL1 protein-DNA interactions in human retinal Müller cells.

Qianyi Luo, Neel Sangani, Surabhi Abhyankar, Sahiti Somalraju, Sarath Chandra Janga, Ashay D Bhatwadekar

Abstract read
In one paragraph

Article in Molecular vision, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qianyi LuoDepartment of Ophthalmology, Indiana University School of Medicine, Eugene and Marilyn Glick Eye Institute, Indianapolis, IN.
Neel SanganiDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing & Engineering, Indiana University Indianapolis (IUI), Indianapolis, IN.
Surabhi AbhyankarDepartment of Ophthalmology, Indiana University School of Medicine, Eugene and Marilyn Glick Eye Institute, Indianapolis, IN.
Sahiti SomalrajuDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing & Engineering, Indiana University Indianapolis (IUI), Indianapolis, IN.
Sarath Chandra JangaDepartment of Biomedical Engineering and Informatics, Luddy School of Informatics, Computing & Engineering, Indiana University Indianapolis (IUI), Indianapolis, IN.
Ashay D BhatwadekarDepartment of Ophthalmology, Indiana University School of Medicine, Eugene and Marilyn Glick Eye Institute, Indianapolis, IN.

Funding

miR-92a as a biomarker of diabetic retinopathyR01EY032080 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI BHATWADEKAR, ASHAY D · 2021 to 2025
$2.6M
Retinal dysfunction in Alzheimer's disease mouse modelsR01EY027779 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI BHATWADEKAR, ASHAY D · 2017 to 2021
$2.4M
Mapping RNA protein interaction networks in the human genomeR01GM123314 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI JANGA, SARATH CHANDRA · 2017 to 2021
$1.7M
NEI NIH HHS R01 EY027779NEI NIH HHS R01EY027779-S1NEI NIH HHS R01 EY032080NIGMS NIH HHS R01 GM123314
6 · The paper itself

Abstract

The circadian clock, a conserved biologic timekeeping mechanism, is pivotal in orchestrating rhythmic physiologic processes. While extensively studied in the central clock, the involvement of BMAL1 in peripheral clocks, particularly in human Müller cells, remains underexplored. Müller cells, critical for retinal homeostasis, may unveil novel insights into circadian regulation. Employing ChIP-sequencing, we comprehensively mapped BMAL1 binding sites in human Müller cells. The analysis identified 275 reproducible peaks, with predominant distribution across promoters (26.6%), intronic (26.3%), and intergenic (22.1%) regions, with 80% of these confident peaks linked to protein-coding genes. Differential peak analysis revealed 89 unique genes significantly enriched with BMAL1 sites in their promoters, while functional enrichment of the associated genes indicated key biologic processes such as circadian regulation of gene expression, photoperiodism, and glucocorticoid receptor signaling pathway regulation. Motif analysis revealed a highly conserved 6-nucleotide motif, CACGTG, appearing in 89.09% of the peaks. Analysis of the binding sites across genomic regions highlighted the robust BMAL1 binding, further confirmed by qPCR validation of circadian targets such as G6PC3, CIART, PER1, and TXNIP, which are critical for Müller cell health, along with SHMT2 and MALAT1, which have emerged as novel genes that may have implications for Müller cell health. Our findings unveil the regulatory landscape of BMAL1 in Müller cells, contributing to a broader understanding of the clock-mediated mechanism in ocular tissues. These insights hold therapeutic potential for circadian-related retinal diseases, presenting avenues for chronotherapeutic interventions.

Indexed as

ARNTL Transcription FactorsDNAEpendymoglial CellsRetinaBinding SitesChromatin Immunoprecipitation SequencingCircadian ClocksCircadian RhythmGene Expression RegulationHumansPromoter Regions, GeneticProtein BindingARNTL Transcription FactorsBMAL1 protein, humanDNA

Identifiers

PMID39959169
PMCPMC11829784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.